PATENT CLAIM ANALYSIS

Application Number: 16113816
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "064000"]

Abstract:
The invention relates to methods of treating cancer, with a combination of an arginase inhibitor and a chemotherapeutic agent. The invention further relates to methods of assessing efficacy of a cancer treatment by measuring arginine levels in a tumor.

Claim (Index 111):
A method of increasing the tumor-killing activity of cytotoxic T-cells in a tumor of a cancer patient, comprising administering an arginase inhibitor to the patient at a dosing regimen that provides a daily therapeutically effective concentration of arginine in the tumor of the patient without resulting in accumulation of arginine in the liver of the patient.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.44828
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15190653', '15853310', '15567838', '15284865', '14394463']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7300684093637649
- 35 USC 102 Novelty (BERT): 0.549237465773595
- Combined Prediction Score: 0.711985315004748
- Mean Citation Score: 303.922088
- Max Citation Score: 397.9382
- Similarity Product: 293.0352896231651

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test